top
Search terms
Results 1 - 6 of 6 - ordered by :
Escardio

(1) The off-label use of the drug led to worse clinical outcomes including a doubled risk of hospitalisation compared to placebo. “Valvular disease is considered the next cardiac epidemic ...

Date : 28/08/2017
Escardio

Pneumonia or sepsis in adults that results in hospital admission is associated with a six-fold increased risk of cardiovascular disease in the first year, according to research published today in the ...

Date : 02/08/2017
Escardio

BARCELONA, Spain – Saturday 30 August: Heart failure patients with iron deficiency can experience significant and sustainable improvements in functional capacity and quality of life as well as ...

Date : 30/08/2014
Escardio

Clinical outcome in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) has progressively improved within the last two decades, in part because of faster diagnosis with invasive ...

Date : 28/08/2018
Escardio

The off-label use of sildenafil in the treatment of residual hypertension in patients with valvular heart disease leads to worse clinical outcomes including a doubled risk of hospitalisation compared ...

Date : 29/08/2017
Escardio

Embargo Sunday 22 May 2011 15.45 CET May 22, 2011- Gothenburg, Sweden : The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation ...

Date : 22/05/2011